Drug Studies
Medicines used to control or eliminate infections and to kill viruses, bacteria, fungi and moulds cannot completely eliminate these microorganisms or fully treat the diseases they cause. Nor can they provide antiviral, antiseptic, antibacterial, antihistaminic, antipruritic and anti-inflammatory effects without damaging the human or animal body and multicellular tissues. Furthermore, there is no biocidal disinfectant with a tissue-compatible pH level. Although drug treatments may reduce the severity of viral infections, they cannot completely cure the disease; therefore, the disease may recur. In addition, existing products cannot completely destroy viruses and bacteria without damaging living cellular tissue and multicellular tissues in humans and animals.
Scientific, laboratory and clinical studies conducted under the scientific name UB20 O8 have shown that, unlike equivalent and similar products, it can eliminate microorganisms with which it comes into contact in less than 10 seconds, achieving values of up to Log 8, without causing any toxic effects, irritation or side effects. In its transparent liquid form, it has a very long shelf life and period of effectiveness and can be ingested, applied topically and inhaled. It combines antiviral, antibacterial, antifungal, antihistaminic, antipruritic, anti-inflammatory, anticancer and antiseptic properties in a single product. Its studies have been published in international academic and scientific publications, making it the only pharmaceutical study of its kind in Türkiye and one of only a limited number worldwide.
It has been proven to be highly effective against all viruses and bacteria that infect humans and other living organisms, including SARS-CoV-2, which causes COVID-19. Although it resembles the biocidal enzymes and myeloperoxidase enzymes produced by our immune system, it has a much more powerful structure. It oxidises and kills all viruses and bacteria within seconds, achieving levels exceeding Log 8, and facilitates their removal from the body. It shortens the treatment period of resulting lesions. Thanks to its anionic structure, it eliminates all cationic pathogens that infect living organisms without harming beneficial bacteria and microorganisms in the body.
Studies conducted over time have demonstrated that it is highly effective against all upper respiratory tract infections; COPD, emphysema, pneumonia, influenza, avian influenza and swine influenza; bactericidal problems such as E. coli and Candida; and many types of cancer and related diseases.
While increasing the body’s oxygen levels, it reduces harmful CRP levels in the blood and facilitates the removal of heavy metals and toxins from the body by oxidising them.
It is particularly effective in the treatment of open wounds and burns, hospital-acquired wounds, pressure ulcers, soft-tissue injuries and dental wounds. It can treat many skin lesions, including shingles and eczema, within a short period.
While scientific and academic studies concerning UB20 O8 Active Anionic Liquid Oxygen continue, the pharmaceutical licensing processes are also progressing rapidly.
It is highly effective against swine influenza, poliovirus, enveloped viruses and all coronaviruses, oxidising and killing all pathogens within seconds.
